UNCY Unicycive Therapeutics

Watchlist

0.6000
-0.0140-2.28%

Trading Mar 31 11:30 ET

65.05MMarket Cap-1.30P/E (TTM)

About Unicycive Therapeutics Company

Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

Company Profile

SymbolUNCY

Company NameUnicycive Therapeutics

Listing DateJul 13, 2021

Issue Price5.00

Founded2016

CEODr. Shalabh Gupta, M.D.

MarketNASDAQ

Employees14

Fiscal Year Ends12-31

Address4300 El Camino Real,Suite 210

CityLos Altos

ProvinceCalifornia

CountryUnited States of America

Zip Code94022

Phone1-650-351-4495

Websitehttp://www.unicycive.com

Company Executives

Name
Position
Salary

Dr. Shalabh Gupta, M.D.
Chief Executive Officer, President and Chairman of the Board
4.07M

John W. Townsend
Chief Financial Officer and Principal Accounting Officer
--

Douglas Jermasek
Executive Vice President, Corporate Strategy
1.27M

Dr. Pramod Gupta, M.D.
Executive Vice President, Pharmaceutical and Business Operations
1.53M

Dr. Saraswati Kenkare-Mitra, PhD
Independent Director
135.58K

Dr. Sandeep Laumas, M.D.
Independent Director
181.02K

Dr. John Ryan, M.D.,PhD
Independent Director
147.22K

Dr. Gaurav Aggarwal, M.D.
Independent Director
138.58K

Market Insights

Symbol Mini Chart % Chg

Unlock the Full List